{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:27:47Z","timestamp":1771946867925,"version":"3.50.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00367","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T04:30:29Z","timestamp":1534912229000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Benjamin","family":"Rolland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Franchitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1001\/archneur.1977.00500190056008","article-title":"Baclofen, a new antispastic drug","volume":"34","author":"Sachais","year":"1977","journal-title":"Arch Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.2174\/1381612821666150619091858","article-title":"GABAB agonists for the treatment of alcohol use disorder","volume":"21","author":"Mirijello","year":"2015","journal-title":"Curr Pharm Des."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/add.14191","article-title":"Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood","volume":"113","author":"Rose","year":"2018","journal-title":"Addiction"},{"key":"B4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/add.13974","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","volume":"113","author":"Palpacuer","year":"2018","journal-title":"Addiction"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2012.00103","article-title":"Suppression of alcohol dependence using baclofen: a 2-year observational study of 100 patients","author":"De","year":"2012","journal-title":"Front Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/alcalc\/ags028","article-title":"Abstinence and \u201clow-risk\u201d consumption 1 year after the initiation of high-dose baclofen: a retrospective study among \u201chigh-risk\u201d drinkers","volume":"47","author":"Rigal","year":"2012","journal-title":"Alcohol Alcohol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1360-0443.2011.03752.x","article-title":"Alcohol-dependence: the current French craze for baclofen","volume":"107","author":"Rolland","year":"2012","journal-title":"Addiction"},{"key":"B8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/JCP.0b013e31824929b2","article-title":"High-dose baclofen for treatment-resistant alcohol dependence","volume":"32","author":"Pastor","year":"2012","journal-title":"J Clin Psychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.euroneuro.2017.08.434","article-title":"Systematic review: baclofen dosing protocols for alcohol use disorders used in observational studies","volume":"27","author":"Thompson","year":"2017","journal-title":"Eur Neuropsychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.euroneuro.2014.08.013","article-title":"The role of GABAB receptors in human reinforcement learning","volume":"24","author":"Ort","year":"2014","journal-title":"Eur Neuropsychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0269881111408463","article-title":"Substitution therapy for alcoholism: time for a reappraisal?","volume":"26","author":"Chick","year":"2012","journal-title":"J Psychopharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/JCP.0b013e3182860e84","article-title":"Baclofen for alcohol-dependence: anticraving or partial substitution?","volume":"33","author":"Rolland","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.euroneuro.2018.03.001","article-title":"The need for patient-tailored dosing of baclofen in future clinical trials","volume":"28","author":"Costa","year":"2018","journal-title":"Eur Neuropsychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2593","DOI":"10.1002\/hup.2593","article-title":"The dose-effect relationship of baclofen in alcohol dependence: a 1-year cohort study","volume":"32","author":"Pignon","year":"2017","journal-title":"Hum Psychopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial","volume":"26","author":"Beraha","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/alcalc\/agx030","article-title":"A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients\u2014the ALPADIR study","author":"Reynaud","year":"2017","journal-title":"Alcohol Alcoholism."},{"key":"B17","unstructured":"JauryP,. High Dose Baclofen for the Treatment of Alcohol Drinkers (BACLOVILLE). Berlin: ISBRA ESBRA World Congress on Alcohol an Alcoholism\n          2016"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.euroneuro.2015.04.002","article-title":"High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial","volume":"25","author":"M\u00fcller","year":"2015","journal-title":"Eur Neuropsychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2515\/therapie\/2015027","article-title":"Use in France of Baclofen for alcohol dependence from 2007 to 2013: cohort study based on the databases SNIIRAM and PMSI","volume":"70","author":"Chaignot","year":"2015","journal-title":"Th\u00e9rapie"},{"key":"B20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40264-016-0489-7","article-title":"Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: an example with baclofen and alcohol dependence in france","volume":"40","author":"Auffret","year":"2017","journal-title":"Drug Saf."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.euroneuro.2015.05.008","article-title":"Baclofen for alcohol dependence: relationships between baclofen and alcohol dosing and the occurrence of major sedation","volume":"25","author":"Rolland","year":"2015","journal-title":"Eur Neuropsychopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2017.1270939","article-title":"Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment","volume":"15","author":"Rolland","year":"2016","journal-title":"Expert Opin Drug Saf."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1523\/JNEUROSCI.18-05-01913.1998","article-title":"Presynaptic GABAB autoreceptor modulation of P\/Q-type calcium channels and GABA release in rat suprachiasmatic nucleus neurons","volume":"18","author":"Chen","year":"1998","journal-title":"J Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/jnr.490390604","article-title":"Role of GABAB receptors in intracellular Ca2+ homeostasis and possible interaction between GABAA and GABAB receptors in regulation of transmitter release in cerebellar granule neurons","volume":"39","author":"Kardos","year":"1994","journal-title":"J Neurosci Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/bcpt.12779","article-title":"Baclofen and alcohol-dependent patients: a real risk of severe self-poisoning","volume":"121","author":"Boels","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/alcalc\/agx072","article-title":"Baclofen self-poisoning in the era of changing indication: multicentric reports to a french poison control centre","volume":"52","author":"L\u00e9ger","year":"2017","journal-title":"Alcohol Alcohol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/15563650.2017","article-title":"Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008\u20132013","volume":"55","author":"Pelissier","year":"2017","journal-title":"Clin Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/17425255.2017.1312340","article-title":"Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians","volume":"13","author":"Franchitto","year":"2017","journal-title":"Exp Opin Drug Metabol Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2007.12.224","article-title":"Life problems and deliberate self-harm: Associations with gender, age, suicidal intent and psychiatric and personality disorder","volume":"109","author":"Haw","year":"2008","journal-title":"J Affect Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/YIC.0000000000000054","article-title":"Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study","volume":"30","author":"Rolland","year":"2015","journal-title":"Int Clin Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/1060028014525594","article-title":"Severe tinnitus induced by off-label baclofen","volume":"48","author":"Auffret","year":"2014","journal-title":"Ann Pharmacother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/bcpt.12344","article-title":"A nationwide register-based survey of baclofen toxicity","volume":"116","author":"Kiel","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/alcalc\/ags076","article-title":"A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol","volume":"47","author":"Rolland","year":"2012","journal-title":"Alcohol Alcohol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1345\/aph.1H202","article-title":"Baclofen-induced psychosis","volume":"40","author":"Chawla","year":"2006","journal-title":"Ann Pharmacother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.psym.2014.02.003","article-title":"Baclofen-induced manic symptoms: case report and systematic review","volume":"55","author":"Geoffroy","year":"2014","journal-title":"Psychosomatics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1523\/JNEUROSCI.2450-14.2015","article-title":"Glutamate input in the dorsal raphe nucleus as a determinant of escalated aggression in male mice","volume":"35","author":"Takahashi","year":"2015","journal-title":"J Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S1566-0702(02)00152-2","article-title":"GABAergic systems in the nucleus tractus solitarius regulate noradrenaline release in the subfornical organ area in the rat","volume":"100","author":"Tanaka","year":"2002","journal-title":"Autonom Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1476-5381.1996.tb16049.x","article-title":"Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats","volume":"119","author":"Tao","year":"1996","journal-title":"Br J Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/alcalc\/agu062","article-title":"Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety","volume":"49","author":"Morley","year":"2014","journal-title":"Alcohol Alcohol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.encep.2016.04.001","article-title":"Does Baclofen have antidepressant qualities?","volume":"42","author":"Geoffroy","year":"2016"},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/jpi.12328","article-title":"GABAergic signaling in the rat pineal gland","volume":"61","author":"Yu","year":"2016","journal-title":"J Pineal Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.brainresbull.2006.08.013","article-title":"Opposite effects of a GABAB antagonist in two models of epileptic seizures in developing rats","volume":"71","author":"Mare\u0161","year":"2006","journal-title":"Brain Res Bull."},{"key":"B43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fneur.2012.00034","article-title":"Revisiting baclofen for the treatment of severe chronic tinnitus","volume":"3","author":"Smith","year":"2012","journal-title":"Front Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1523\/JNEUROSCI.4989-12.2013","article-title":"GABAB receptors regulate extrasynaptic GABAA receptors","volume":"33","author":"Connelly","year":"2013","journal-title":"J Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mcn.2014.04.001","article-title":"GABAA receptor subunit composition and competition at synapses are tuned by GABAB receptor activity","volume":"60","author":"Gerrow","year":"2014","journal-title":"Mol Cell Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.chest.2015.10.001","article-title":"Severe central sleep apnea associated with chronic baclofen therapy","volume":"149","author":"Olivier","year":"2016","journal-title":"Chest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0006-8993(93)91358-Y","article-title":"Effects of GABAB receptor agonists and antagonists on the bulbar respiratory network in cat","volume":"605","author":"Pierrefiche","year":"1993","journal-title":"Brain Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/JCP.0000000000000054","article-title":"Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder","volume":"34","author":"Rolland","year":"2014","journal-title":"J Clin Psychopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fpsyt.2014.00143","article-title":"The use of very high-doses of baclofen for the treatment of alcohol-dependence: a case series","volume":"5","author":"de","year":"2014","journal-title":"Front Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/alcalc\/agv052","article-title":"Tolerability of high-dose baclofen in the treatment of patients with alcohol disorders: a retrospective study","volume":"50","author":"Rigal","year":"2015","journal-title":"Alcohol Alcohol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jcph.233","article-title":"Baclofen-induced edema in alcohol use disorders","volume":"54","author":"Bence","year":"2014","journal-title":"J Clin Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1742-6723.2006.00805.x","article-title":"Baclofen overdose: defining the spectrum of toxicity","volume":"18","author":"Leung","year":"2006","journal-title":"Emerg Med Aust."},{"key":"B53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000362409","article-title":"Death of an alcohol-dependent patient following intentional drug intoxication: implication of baclofen?","volume":"20","author":"Pape","year":"2014","journal-title":"Eur Addict Res"},{"key":"B54","unstructured":"Real-Life Baclofen in France Between 2009 and 2015: Uses, Safety, and Comparison With on-Label Drugs for Alcohol Use Disorders2017"},{"key":"B55","unstructured":"VillierC\n            SchirE\n            MallaretM\n          Adverse Effects of Baclofen in the Treatment of Addictions: 2011 National Pharmacovigilance Monitoring2012"},{"key":"B56","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2017.05.003","article-title":"Baclofen and alcohol use disorders: from miracle to mirage","volume":"27","author":"Braillon","year":"2017","journal-title":"Eur Neuropsychopharmacol."},{"key":"B57","unstructured":"NaassilaM\n            PailleF\n            Soci\u00e9t\u00e9Fran\u00e7aise d'Alcoologie\n          Baclofen and Alcohol Use: What Can be Said in 20182018"},{"key":"B58","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/fcp.12332","article-title":"On-the-ground application of the \u201ctemporary recommendation for use\u201d regulatory measure on off-label use of baclofen for alcohol dependence in France: A regional survey of community pharmacies","volume":"32","author":"Auffret","year":"2017","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00367\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T04:30:40Z","timestamp":1534912240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00367\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":58,"alternative-id":["10.3389\/fpsyt.2018.00367"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00367","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"article-number":"367"}}